re: Well this confirms what many of us with reservations about Vivek suspected.

Just because of the OP's link I looked into Roivant. This company is bleeding cash. Has never made money but the market cap has been increasing quarter over quarter expect for the last quarter.


This is not investment advice but my initial impression this looks like a good opportunity to research for a small but potentially very profitable short.

Unless Roivant is on some cutting edge drug that is about to hit the market they look like they are headed for bankruptcy.